カテゴリ： 世界, 医療/バイオ, Market Monitor Global

受容体チロシンプロテインキナーゼERBB 3のグローバル市場展望 2023年-2029年：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他

■ 英語タイトル：Receptor Tyrosine Protein Kinase ERBB 3 Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8626）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8626
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[受容体チロシンプロテインキナーゼERBB 3のグローバル市場展望 2023年-2029年：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の受容体チロシンプロテインキナーゼERBB 3市場規模と予測を収録しています。・世界の受容体チロシンプロテインキナーゼERBB 3市場：売上、2018年-2023年、2024年-2029年
・世界の受容体チロシンプロテインキナーゼERBB 3市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の受容体チロシンプロテインキナーゼERBB 3市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「BA-0702」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

受容体チロシンプロテインキナーゼERBB 3のグローバル主要企業は、AstraZeneca Plc、 AVEO Pharmaceuticals, Inc.、 Etubics Corporation、 F. Hoffmann-La Roche Ltd.、 GamaMabs Pharma S.A.、 GlaxoSmithKline Plc、 Hanmi Pharmaceuticals, Co. Ltd.、 ImmunoGen, Inc.、 Kolltan Pharmaceuticals, Inc.、 Merrimack Pharmaceuticals, Inc.、 Merus B.V.、 Novartis AG、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Sihuan Pharmaceutical Holdings Group Ltd.、 Sorrento Therapeutics, Inc.、 Symphogen A/S、 Takis S.r.l.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、受容体チロシンプロテインキナーゼERBB 3のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の受容体チロシンプロテインキナーゼERBB 3市場：タイプ別、2018年-2023年、2024年-2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場：タイプ別市場シェア、2022年
・BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他

世界の受容体チロシンプロテインキナーゼERBB 3市場：用途別、2018年-2023年、2024年-2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場：用途別市場シェア、2022年
・非小細胞癌、固形腫瘍、黒色腫、結腸直腸癌、その他

世界の受容体チロシンプロテインキナーゼERBB 3市場：地域・国別、2018年-2023年、2024年-2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル売上、2018年-2023年
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル売上シェア、2022年
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル販売量、2018年-2023年
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AstraZeneca Plc、 AVEO Pharmaceuticals, Inc.、 Etubics Corporation、 F. Hoffmann-La Roche Ltd.、 GamaMabs Pharma S.A.、 GlaxoSmithKline Plc、 Hanmi Pharmaceuticals, Co. Ltd.、 ImmunoGen, Inc.、 Kolltan Pharmaceuticals, Inc.、 Merrimack Pharmaceuticals, Inc.、 Merus B.V.、 Novartis AG、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Sihuan Pharmaceutical Holdings Group Ltd.、 Sorrento Therapeutics, Inc.、 Symphogen A/S、 Takis S.r.l.

*************************************************************

・調査・分析レポートの概要
受容体チロシンプロテインキナーゼERBB 3市場の定義
市場セグメント
世界の受容体チロシンプロテインキナーゼERBB 3市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の受容体チロシンプロテインキナーゼERBB 3市場規模
世界の受容体チロシンプロテインキナーゼERBB 3市場規模：2022年 VS 2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの受容体チロシンプロテインキナーゼERBB 3の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の受容体チロシンプロテインキナーゼERBB 3製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他
受容体チロシンプロテインキナーゼERBB 3のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：非小細胞癌、固形腫瘍、黒色腫、結腸直腸癌、その他
受容体チロシンプロテインキナーゼERBB 3の用途別グローバル売上・予測

・地域別市場分析
地域別受容体チロシンプロテインキナーゼERBB 3市場規模 2022年と2029年
地域別受容体チロシンプロテインキナーゼERBB 3売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca Plc、 AVEO Pharmaceuticals, Inc.、 Etubics Corporation、 F. Hoffmann-La Roche Ltd.、 GamaMabs Pharma S.A.、 GlaxoSmithKline Plc、 Hanmi Pharmaceuticals, Co. Ltd.、 ImmunoGen, Inc.、 Kolltan Pharmaceuticals, Inc.、 Merrimack Pharmaceuticals, Inc.、 Merus B.V.、 Novartis AG、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Sihuan Pharmaceutical Holdings Group Ltd.、 Sorrento Therapeutics, Inc.、 Symphogen A/S、 Takis S.r.l.
...

This report aims to provide a comprehensive presentation of the global market for Receptor Tyrosine Protein Kinase ERBB 3, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Receptor Tyrosine Protein Kinase ERBB 3. This report contains market size and forecasts of Receptor Tyrosine Protein Kinase ERBB 3 in global, including the following market information:
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Receptor Tyrosine Protein Kinase ERBB 3 companies in 2022 (%)
The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
BA-0702 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Receptor Tyrosine Protein Kinase ERBB 3 include AstraZeneca Plc, AVEO Pharmaceuticals, Inc., Etubics Corporation, F. Hoffmann-La Roche Ltd., GamaMabs Pharma S.A., GlaxoSmithKline Plc, Hanmi Pharmaceuticals, Co. Ltd., ImmunoGen, Inc. and Kolltan Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Receptor Tyrosine Protein Kinase ERBB 3 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, by Type, 2022 (%)
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, by Application, 2022 (%)
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Receptor Tyrosine Protein Kinase ERBB 3 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 revenues share in global market, 2022 (%)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Receptor Tyrosine Protein Kinase ERBB 3, market overview.
Chapter 2: Global Receptor Tyrosine Protein Kinase ERBB 3 market size in revenue and volume.
Chapter 3: Detailed analysis of Receptor Tyrosine Protein Kinase ERBB 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Receptor Tyrosine Protein Kinase ERBB 3 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Receptor Tyrosine Protein Kinase ERBB 3 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Receptor Tyrosine Protein Kinase ERBB 3 Overall Market Size
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size: 2022 VS 2029
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales: 2018-2029
3 Company Landscape
3.1 Top Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market
3.2 Top Global Receptor Tyrosine Protein Kinase ERBB 3 Companies Ranked by Revenue
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Companies
3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Companies
3.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Receptor Tyrosine Protein Kinase ERBB 3 Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market
3.8.1 List of Global Tier 1 Receptor Tyrosine Protein Kinase ERBB 3 Companies
3.8.2 List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Markets, 2022 & 2029
4.1.2 BA-0702
4.1.3 CDX-3379
4.1.4 Elgemtumab
4.1.5 ETBX-031
4.1.6 Others
4.2 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
4.2.1 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2023
4.2.2 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2024-2029
4.2.3 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
4.3 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
4.3.1 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2023
4.3.2 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2024-2029
4.3.3 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
4.4 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2022 & 2029
5.1.2 Non-Small Cell Carcinoma
5.1.3 Solid Tumor
5.1.4 Melanoma
5.1.5 Colorectal Cancer
5.1.6 Others
5.2 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
5.2.1 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2023
5.2.2 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2024-2029
5.2.3 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
5.3 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
5.3.1 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2023
5.3.2 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2024-2029
5.3.3 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
5.4 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2022 & 2029
6.2 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
6.2.1 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2023
6.2.2 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2024-2029
6.2.3 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
6.3 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
6.3.1 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2023
6.3.2 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2024-2029
6.3.3 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.4.2 By Country – North America Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.4.3 US Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.4.4 Canada Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.4.5 Mexico Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.5.2 By Country – Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.5.3 Germany Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.4 France Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.5 U.K. Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.6 Italy Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.7 Russia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.8 Nordic Countries Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.9 Benelux Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.6.2 By Region – Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.6.3 China Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.5 South Korea Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.6 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.7 India Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.7.2 By Country – South America Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.7.3 Brazil Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.7.4 Argentina Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.8.3 Turkey Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8.4 Israel Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8.5 Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8.6 UAE Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Company Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Plc Key News & Latest Developments
7.2 AVEO Pharmaceuticals, Inc.
7.2.1 AVEO Pharmaceuticals, Inc. Company Summary
7.2.2 AVEO Pharmaceuticals, Inc. Business Overview
7.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.2.5 AVEO Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Etubics Corporation
7.3.1 Etubics Corporation Company Summary
7.3.2 Etubics Corporation Business Overview
7.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.3.5 Etubics Corporation Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Company Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.5 GamaMabs Pharma S.A.
7.5.1 GamaMabs Pharma S.A. Company Summary
7.5.2 GamaMabs Pharma S.A. Business Overview
7.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.5.5 GamaMabs Pharma S.A. Key News & Latest Developments
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Company Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Plc Key News & Latest Developments
7.7 Hanmi Pharmaceuticals, Co. Ltd.
7.7.1 Hanmi Pharmaceuticals, Co. Ltd. Company Summary
7.7.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
7.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.7.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.7.5 Hanmi Pharmaceuticals, Co. Ltd. Key News & Latest Developments
7.8 ImmunoGen, Inc.
7.8.1 ImmunoGen, Inc. Company Summary
7.8.2 ImmunoGen, Inc. Business Overview
7.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.8.5 ImmunoGen, Inc. Key News & Latest Developments
7.9 Kolltan Pharmaceuticals, Inc.
7.9.1 Kolltan Pharmaceuticals, Inc. Company Summary
7.9.2 Kolltan Pharmaceuticals, Inc. Business Overview
7.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.9.5 Kolltan Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Merrimack Pharmaceuticals, Inc.
7.10.1 Merrimack Pharmaceuticals, Inc. Company Summary
7.10.2 Merrimack Pharmaceuticals, Inc. Business Overview
7.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.10.5 Merrimack Pharmaceuticals, Inc. Key News & Latest Developments
7.11 Merus B.V.
7.11.1 Merus B.V. Company Summary
7.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.11.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.11.5 Merus B.V. Key News & Latest Developments
7.12 Novartis AG
7.12.1 Novartis AG Company Summary
7.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.12.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.12.5 Novartis AG Key News & Latest Developments
7.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Summary
7.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
7.14 Sihuan Pharmaceutical Holdings Group Ltd.
7.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Summary
7.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
7.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Key News & Latest Developments
7.15 Sorrento Therapeutics, Inc.
7.15.1 Sorrento Therapeutics, Inc. Company Summary
7.15.2 Sorrento Therapeutics, Inc. Business Overview
7.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.15.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.15.5 Sorrento Therapeutics, Inc. Key News & Latest Developments
7.16 Symphogen A/S
7.16.1 Symphogen A/S Company Summary
7.16.2 Symphogen A/S Business Overview
7.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.16.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.16.5 Symphogen A/S Key News & Latest Developments
7.17 Takis S.r.l.
7.17.1 Takis S.r.l. Company Summary
7.17.2 Takis S.r.l. Business Overview
7.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.17.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.17.5 Takis S.r.l. Key News & Latest Developments
8 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity, Analysis
8.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity, 2018-2029
8.2 Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity of Key Manufacturers in Global Market
8.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Receptor Tyrosine Protein Kinase ERBB 3 Supply Chain Analysis
10.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Value Chain
10.2 Receptor Tyrosine Protein Kinase ERBB 3 Upstream Market
10.3 Receptor Tyrosine Protein Kinase ERBB 3 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ラウレス-3のグローバル市場展望 2023年-2029年：99%（含有量）、99.5%（含有量）、その他
  • アセチルテトラペプチド-3のグローバル市場展望 2023年-2029年：純度98%以下、純度98%-99%、純度99%以上
  • チロシンプロテインキナーゼマーの世界市場2023年：プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1
  • Rho関連プロテインキナーゼ2の世界市場2023年：AN-3485、KL-01045、AT-13148、TRX-101、その他
  • バソプレシンV1b受容体のグローバル市場展望 2023年-2029年：PHT-103、ABT-436、AVN-628、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8626 )"受容体チロシンプロテインキナーゼERBB 3のグローバル市場展望 2023年-2029年：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他" (英文：Receptor Tyrosine Protein Kinase ERBB 3 Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。